Immucell Corp (ICCC) Reports Q4 Loss of $0.32

Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of ($0.32). Revenue for the quarter came in at $18.57 million, versus $0 reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Target raises full-year sales forecast amid ongoing turnaround drive
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance